Prognosis of metastatic castration-resistant prostate cancer in response to chemotherapy and PSMA expression in circulating tumor cells

被引:0
|
作者
Nagaya, N. [1 ]
Nagata, M. [1 ]
Ashizawa, T. [1 ]
Lu, Y. [1 ]
Fujita, K. [1 ]
Horie, S. [1 ]
机构
[1] Juntendo Univ, Urol, Grad Sch Med, Bunkyo ku, Tokyo, Japan
关键词
D O I
10.1016/j.annonc.2023.10.401
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
275P
引用
收藏
页码:S1579 / S1580
页数:2
相关论文
共 50 条
  • [41] Luminal and basal subtyping of circulating tumor cells and influence on outcomes in patients with metastatic castration-resistant prostate cancer
    Wang, Jasmine Jiemei
    Kim, Minhyung
    Teng, Pai-Chi
    Jan, Yu Jen
    Chen, Jie-Fu
    Zhu, Yazhen
    You, Sungyong
    Tseng, Hsian-Rong
    Posadas, Edwin Melencio
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Clinical validation of circulating cytokines as markers of prognosis and response to docetaxel in men with metastatic castration-resistant prostate cancer.
    Mahon, Kate Lynette
    Lin, Hui-Ming
    Lee-Ng, Michelle
    Stockler, Martin R.
    Gurney, Howard
    Mallesara, Girish
    Briscoe, Karen P.
    Marx, Gavin M.
    Higano, Celestia S.
    De Bono, Johann S.
    Chi, Kim N.
    Brown, David
    Breit, Samuel N.
    Horvath, Lisa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [43] Chemotherapy for castration-resistant prostate cancer
    Berthold, D.
    ONKOLOGIE, 2011, 34 : 12 - 12
  • [44] Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving 177Lu-PSMA-617 Radioligand Therapy
    Kessel, Katharina
    Seifert, Robert
    Weckesser, Matthias
    Roll, Wolfgang
    Humberg, Verena
    Schlack, Katrin
    Boegemann, Martin
    Bernemann, Christof
    Rahbar, Kambiz
    THERANOSTICS, 2020, 10 (17): : 7645 - 7655
  • [45] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sanli, Yasemin
    Simsek, Duygu Has
    Sanli, Oner
    Subramaniam, Rathan M.
    Kendi, Ayse Tuba
    BIOMEDICINES, 2021, 9 (04)
  • [46] Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
    Sartor, Oliver
    de Bono, Johann
    Chi, Kim N.
    Fizazi, Karim
    Herrmann, Ken
    Rahbar, Kambiz
    Tagawa, Scott T.
    Nordquist, Luke T.
    Vaishampayan, Nitin
    El-Haddad, Ghassan
    Park, Chandler H.
    Beer, Tomasz M.
    Armour, Alison
    Perez-Contreras, Wendy J.
    DeSilvio, Michelle
    Kpamegan, Euloge
    Gericke, Germo
    Messmann, Richard A.
    Morris, Michael J.
    Krause, Bernd J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (12): : 1091 - 1103
  • [47] A Circulating Tumor Cell RNA Assay for Prognostication of Patients with Metastatic Castration-resistant Prostate Cancer
    Wang, Jasmine
    Kim, Minhyung
    Teng, Pai-Chi
    Jan, Yu Jen
    Chen, Jie-Fu
    Shi, Lucy Ruoxi
    You, Sungyong
    Tseng, Hsian-Rong
    Posadas, Edwin
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1568 - S1569
  • [48] Increased circulating polymorphonuclear myeloid-derived suppressor cells are associated with prognosis of metastatic castration-resistant prostate cancer
    Kobayashi, Takuro
    Nagata, Masayoshi
    Hachiya, Tsuyoshi
    Wakita, Haruhiko
    Ikehata, Yoshihiro
    Takahashi, Keiji
    China, Toshiyuki
    Shimizu, Fumitaka
    Lu, Jun
    Jin, Yiming
    Lu, Yan
    Ide, Hisamitsu
    Horie, Shigeo
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [49] Combination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer
    Chang, Kun
    Kong, Yun-Yi
    Dai, Bo
    Ye, Ding-Wei
    Qu, Yuan-Yuan
    Wang, Yue
    Jia, Zhong-Wei
    Li, Gao-Xiang
    ONCOTARGET, 2015, 6 (39) : 41825 - 41836
  • [50] TUMOR MARKER DETECTION AS THE COMPLEMENT TO CIRCULATING TUMOR CELL ENUMERATION IN PREDICTING PROGNOSIS AND TREATMENT EFFECT IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Chang, Kun
    Dai, Bo
    Ye, Ding-wei
    JOURNAL OF UROLOGY, 2016, 195 (04): : E82 - E82